Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Clinical trial NCT02558348 · TERMINATED
Trial details
- NCT number
- NCT02558348
- Sponsor
- Advenchen Laboratories, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-02-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.